Kiniksa Pharmaceuticals International Plc (KNSA)
45.63
+0.48
(+1.06%)
USD |
NASDAQ |
Mar 19, 16:00
45.61
-0.02
(-0.04%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International EPS Diluted (Quarterly) : 0.1741 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1193 |
| NovoCure Ltd. | -0.2183 |
| LivaNova Plc | 0.5566 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Alterola Biotech, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 14.20M |
| Revenue (Quarterly) | 202.13M |
| Total Expenses (Quarterly) | 187.93M |
| Enterprise Value | 3.088B |
| Gross Profit Margin (Quarterly) | 54.93% |
| Profit Margin (Quarterly) | 7.02% |
| Earnings Yield | 1.63% |
| Operating Earnings Yield | 2.14% |
| Normalized Earnings Yield | 1.633 |